Literature DB >> 25350684

Recruitment difficulties in obstetric trials: a case study and review.

Arushi Madan1, Sally Tracy, Rachel Reid, Amanda Henry.   

Abstract

BACKGROUND: The CONSORT statement calls for complete data on flow of participants, including all losses and exclusions. Incomplete reporting of flow into trials versus flow through trials is not uncommon. Where complete data exist in obstetric trials, poor recruitment seems a recurring theme. AIMS: To explore difficulties in recruitment and differences between assessed-but-not-recruited and included women to improve future trial participation, using a case study of a recently published randomised trial of outpatient Foley catheter versus inpatient PGE2 gel for cervical ripening. MATERIALS &
METHODS: The assessed-but-not-recruited population of an obstetric trial (ACTRN:12609000420246) was prospectively studied for reasons for noninclusion, demographic data and pregnancy outcome. Women assessed-but-not-recruited due to declined consent or obstetrician declined participation were compared to included women. Main outcome measures included demographic and outcome differences associated with trial participation.
RESULTS: Of 468 assessed participants, 220 (47%) were not eligible by exclusion criteria (potential 'trial factor' recruitment difficulties), 147 (31%) declined consent (n = 100, 'participant factor') or their obstetrician declined participation (n = 47, 'clinician factor') and 101 (22%) were included. Declining women were more likely than participants to be parous (24 vs 10%, P < 0.05), induced for nonmedical reasons (18 vs 4%, P < 0.001), privately admitted (31 vs 3%, P < 0.001) and have longer inpatient stay (4.9 vs 4.2 days, P < 0.05).
CONCLUSION: The high assessed-but-not-recruited rate highlights important issues with external validity and feasibility when conducting obstetric trials, including recruitment difficulties related to participant, clinician and trial factors. Assessed: recruited ratios and demographic and outcome differences need consideration in planning and interpretation of randomised trials.
© 2014 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  external validity; induction of labour; obstetrics; randomised controlled trials; recruitment

Mesh:

Year:  2014        PMID: 25350684     DOI: 10.1111/ajo.12233

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  7 in total

1.  Engagement with and outcomes of a Midwifery-led intervention group for pregnant women of high body mass index.

Authors:  Sarah R Chwah; Amanda Reilly; Beverley Hall; Anthony J O'Sullivan; Amanda Henry
Journal:  Obstet Med       Date:  2016-04-29

Review 2.  Perinatal epidemiology: Issues, challenges, and potential solutions.

Authors:  Konstantinos Giannakou
Journal:  Obstet Med       Date:  2020-09-01

3.  A qualitative study on acceptable levels of risk for pregnant women in clinical research.

Authors:  Indira S E van der Zande; Rieke van der Graaf; Martijn A Oudijk; Johannes J M van Delden
Journal:  BMC Med Ethics       Date:  2017-05-15       Impact factor: 2.652

4.  Predicting completion of clinical trials in pregnant women: Cox proportional hazard and neural network models.

Authors:  Bomee Kim; Yun Ji Jang; Hae Ram Cho; So Yeon Kim; Ji Eun Jeong; Mi Kyoung Shim; Myeong Gyu Kim
Journal:  Clin Transl Sci       Date:  2021-11-17       Impact factor: 4.689

5.  A Comparison of Recruitment Methods for a Prospective Cohort Study of Perinatal Psychoneuroimmunology among Black American Women.

Authors:  Shannon L Gillespie
Journal:  J Urban Health       Date:  2021-06-21       Impact factor: 5.801

6.  A Practical Do-It-Yourself Recruitment Framework for Concurrent eHealth Clinical Trials: Simple Architecture (Part 1).

Authors:  Hannah L Palac; Nameyeh Alam; Susan M Kaiser; Jody D Ciolino; Emily G Lattie; David C Mohr
Journal:  J Med Internet Res       Date:  2018-11-01       Impact factor: 5.428

Review 7.  The moral imperative to approve pregnant women's participation in randomized clinical trials for pregnancy and newborn complications.

Authors:  Dan Kabonge Kaye
Journal:  Philos Ethics Humanit Med       Date:  2019-09-06       Impact factor: 2.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.